Cdk phosphorylation of Chk1 regulates efficient Chk1 activation and multiple checkpoint proficiency

被引:6
|
作者
Xu, Naihan [1 ,2 ]
Libertini, Silvana [2 ]
Zhang, Yaou [1 ]
Gillespie, David A. [2 ,3 ]
机构
[1] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518055, Peoples R China
[2] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[3] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
关键词
Chk1; Cdk; S/M checkpoint; G2/M checkpoint; Cell cycle; DOUBLE-STRAND BREAKS; DNA-DAMAGE; S-PHASE; RECRUITMENT; SURVIVAL; REPAIR; CELLS; ATR;
D O I
10.1016/j.bbrc.2011.08.119
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been reported previously that both Cdk1 and Cdk2 phosphorylate Chk1 in a cell-cycle dependent manner. Cdk-mediated phosphorylation is required for efficient activation of Chk1 and checkpoint proficiency in response to DNA damage. Here, we demonstrate that Cdk-mediated phosphorylation is also required for replication stress induced Chk1 activation and S/M checkpoint proficiency. Re-introduction of Chk1 mutant (S286A/S301A) into Chk1 deficient cells is capable of restraining mitosis in cells with completely unreplicated DNA, but the mitotic delay at later stage of the cell cycle is largely impaired. The mutation strongly attenuates aphidicolin induced Chk1 activation without altering the S-phase dependent Chk1 activation. These data indicate that Cdk-mediated phosphorytion is required for efficient Chk1 activation and multiple checkpoint proficiency. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:465 / 470
页数:6
相关论文
共 50 条
  • [1] Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage
    N Xu
    S Libertini
    E J Black
    Y Lao
    N Hegarat
    M Walker
    D A Gillespie
    Oncogene, 2012, 31 : 1086 - 1094
  • [2] Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage
    Xu, N.
    Libertini, S.
    Black, E. J.
    Lao, Y.
    Hegarat, N.
    Walker, M.
    Gillespie, D. A.
    ONCOGENE, 2012, 31 (09) : 1086 - 1094
  • [3] Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition
    Parsels, Leslie A.
    Qian, Yushen
    Tanska, Daria M.
    Gross, Marisa
    Zhao, Lili
    Hassan, Maria C.
    Arumugarajah, Sankari
    Parsels, Joshua D.
    Hylander-Gans, Linda
    Simeone, Diane M.
    Morosini, Deborah
    Brown, Jeffrey L.
    Zabludoff, Sonya D.
    Maybaum, Jonathan
    Lawrence, Theodore S.
    Morgan, Meredith A.
    CLINICAL CANCER RESEARCH, 2011, 17 (11) : 3706 - 3715
  • [4] Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity
    M Walker
    E J Black
    V Oehler
    D A Gillespie
    M T Scott
    Oncogene, 2009, 28 : 2314 - 2323
  • [5] Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity
    Walker, M.
    Black, E. J.
    Oehler, V.
    Gillespie, D. A.
    Scott, M. T.
    ONCOGENE, 2009, 28 (24) : 2314 - 2323
  • [6] Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation
    Yu, Xinfang
    Li, Wei
    Liu, Haidan
    Deng, Qipan
    Wang, Xu
    Hu, Hui
    Xu-Monette, Zijun Y.
    Xiong, Wei
    Lu, Zhongxin
    Young, Ken H.
    Wang, Wei
    Li, Yong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [7] Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation
    Xinfang Yu
    Wei Li
    Haidan Liu
    Qipan Deng
    Xu Wang
    Hui Hu
    Zijun Y. Xu-Monette
    Wei Xiong
    Zhongxin Lu
    Ken H. Young
    Wei Wang
    Yong Li
    Journal of Hematology & Oncology, 13
  • [8] The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability
    Chen, Yue
    Poon, Randy Y. C.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 5016 - 5029
  • [9] Global Analysis of Phosphorylation of Tau by the Checkpoint Kinases Chk1 and Chk2 in vitro
    Mendoza, Jhoana
    Sekiya, Michiko
    Taniguchi, Taizo
    Iijima, Koichi M.
    Wang, Rong
    Ando, Kanae
    JOURNAL OF PROTEOME RESEARCH, 2013, 12 (06) : 2654 - 2665
  • [10] Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints
    Pabla, Navjotsingh
    Bhatt, Kirti
    Dong, Zheng
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (01) : 197 - 202